Cargando…
Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic?
Although firms with sustainable competitive advantage do not yield superior returns in regular years, these firms significantly outperform others during the Covid-19 pandemic. Empirical evidence shows that wide-moat is positively priced by the stock market during the pandemic, which is not the case...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015958/ https://www.ncbi.nlm.nih.gov/pubmed/35463296 http://dx.doi.org/10.1016/j.frl.2022.102893 |
_version_ | 1784688425242198016 |
---|---|
author | Yu, Huaibing |
author_facet | Yu, Huaibing |
author_sort | Yu, Huaibing |
collection | PubMed |
description | Although firms with sustainable competitive advantage do not yield superior returns in regular years, these firms significantly outperform others during the Covid-19 pandemic. Empirical evidence shows that wide-moat is positively priced by the stock market during the pandemic, which is not the case in the pre-pandemic period. Furthermore, wide-moat firms can generate positive cumulative abnormal returns after the advent of the Covid-19 pandemic. However, the magnitude wanes down as time expands into the future. |
format | Online Article Text |
id | pubmed-9015958 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90159582022-04-19 Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? Yu, Huaibing Financ Res Lett Article Although firms with sustainable competitive advantage do not yield superior returns in regular years, these firms significantly outperform others during the Covid-19 pandemic. Empirical evidence shows that wide-moat is positively priced by the stock market during the pandemic, which is not the case in the pre-pandemic period. Furthermore, wide-moat firms can generate positive cumulative abnormal returns after the advent of the Covid-19 pandemic. However, the magnitude wanes down as time expands into the future. Elsevier Inc. 2022-08 2022-04-19 /pmc/articles/PMC9015958/ /pubmed/35463296 http://dx.doi.org/10.1016/j.frl.2022.102893 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Yu, Huaibing Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title | Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title_full | Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title_fullStr | Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title_full_unstemmed | Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title_short | Does sustainable competitive advantage make a difference in stock performance during the Covid-19 pandemic? |
title_sort | does sustainable competitive advantage make a difference in stock performance during the covid-19 pandemic? |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015958/ https://www.ncbi.nlm.nih.gov/pubmed/35463296 http://dx.doi.org/10.1016/j.frl.2022.102893 |
work_keys_str_mv | AT yuhuaibing doessustainablecompetitiveadvantagemakeadifferenceinstockperformanceduringthecovid19pandemic |